Human cytotoxic T-cell responses against Epstein-Barr virus nuclear antigens demonstrated by using recombinant vaccinia viruses.
R J Murray(University of Birmingham), Elliott Kieff(Brigham and Women's Hospital), Denis J. Moss(The University of Queensland), Michael G. Kurilla(QIMR Berghofer Medical Research Institute), Scott R. Burrows(Australian National University), Martin Rowe(University of Wales), J. R. Arrand(University of Birmingham), M. Mackett(University of Birmingham), H Griffin(University of Birmingham), Jill Brooks(Immune Regulation (United Kingdom))
Cited by 103
Related Papers
Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development.
|The Journal of Experimental Medicine|1992|391
Epstein–Barr virus latent genes
|Experimental & Molecular Medicine|2015|362
Activation and adoptive transfer of Epstein–Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease
|Proceedings of the National Academy of Sciences|1999|332